The 7 hidden factors that decide whether your medtech startup will scale or stall 

Every week, new MedTech startups emerge with promises to transform healthcare, yet many never make it past a pilot. Despite groundbreaking technologies, it’s not failure in the lab that trips most ventures up, but failure in the market. According to EvoMed Consulting, the core issue is a strategic blind spot: many founders overlook the hidden forces that determine clinical adoption, reimbursement, and scale. 

In their whitepaper “Why Most MedTech Startups Fail”, EvoMed distills years of research, clinical leadership, and venture advisory into a clear framework of seven factors that consistently determine whether a MedTech innovation takes off or stalls. Together, these elements form the EMC StarMap, a practical tool that helps founders assess and strengthen their strategy across all critical domains.

Also read: Calling All MedTech Innovators: It’s Time to Nominate for MedTech Malta 2025 Awards

From innovation to integration: the seven constellation points 

1. Specialization & clinical depth Success doesn’t come from building a product for everyone. It comes from solving a defined, urgent problem for a clearly targeted patient group. Specialization builds clinical credibility and relevance. “If you try to be everything to everyone, you risk being no one’s first choice,” the whitepaper notes. 
2. Predictability of services Technologies that disrupt clinical workflows without clear advantages are likely to be resisted. Scalable solutions must improve efficiency, reduce variability, and slot into real-world hospital routines with minimal training or disruption. 
3. Ambulantization & digital care models As care shifts beyond hospitals into outpatient clinics and patients’ homes, MedTech needs to keep pace. Tools that only work in traditional hospital settings may soon be obsolete. Over 75% of MedTech leaders say they’re rethinking their strategies to accommodate this shift. 
4. Cooperation & ecosystem fit Interoperability and collaboration are non-negotiable. Tools that don’t integrate with existing systems (like EHRs) or fail to support cross-provider coordination often end up as siloed and unused. “Future success will depend on targeting the entire care pathway, not just standalone products,” notes 86% of MedTech executives surveyed. 
5. Economic viability Even a clinically brilliant tool will stall if hospitals can’t justify the cost. ROI, reimbursement pathways, and a compelling business case are all essential. It’s not just about clinical benefit; it’s about financial sustainability for all stakeholders. 
6. Quality of care & patient outcomes Evidence of improved outcomes is fast becoming the gold standard. Whether it’s fewer readmissions, faster recovery, or higher patient satisfaction, measurable impact is now a key driver of adoption and funding. 
7. Implementation friction The best product means nothing if it never gets used. Lengthy onboarding, resistance from staff, IT challenges, or regulatory delays can derail even the most promising solution. Minimizing this friction is critical to scaling adoption. 

Also read: Ecosystem report: MedTech World Bay Area 2025: bridging startups, capital, and clinical impact

Why alignment matters more than ambition 

A standout insight from the whitepaper: most of these success factors are not isolated. They’re interconnected. A weakness in one area—say, integration—can undermine others, like outcomes or reimbursement. This is why EMC developed the StarMap: to help startups visualize how these domains interact, identify blind spots early, and design stronger, more fundable businesses. 

By mapping each company’s strengths and gaps across the seven “Constellation Points,” founders gain a strategic compass tailored to the real-world complexity of healthcare. It’s not another theory—it’s a diagnostic toolkit, developed by clinicians and consultants who’ve seen too many good ideas fail for the wrong reasons. 

As Dr. Amel Havkic, founder of EvoMed Consulting, puts it: 

“You don’t need another theory. You need actionable clarity. That’s what I’ve built StarMap to deliver.” 

Join us at MedTech Malta 2025 

Want to hear more from the minds helping startups cross the chasm from idea to impact? Join us at MedTech Malta 2025 from 12 to 14 November in Valletta, Malta. Meet founders, investors, and industry leaders charting the next frontier of healthtech. For info, partnerships, or to attend: [email protected]